QFT
4 FDA 510(k) clearances · Product code
FDA profile
- Official device name
- Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 882.5803
- Medical specialty
- Obstetrics/Gynecology
- FDA definition
- A digital therapy device for Attention Deficit Hyperactivity Disorder (ADHD) is a software intended to provide therapy for ADHD or any of its individual symptoms as an adjunct to clinician supervised treatment.
Export predicate table (CSV) Shareable report ◉ Watch exports: 3 free/month · reports & watching: free
| Record | Firm | Date |
|---|---|---|
| Prismira (K243729) | Lumos Labs, Inc. | 2025-06-13 |
| EndeavorOTC (K233496) | Akili Interactive Labs, Inc. | 2024-06-14 |
| EndeavorRx (K231337) | Akili Interactive Labs, Inc. | 2023-12-13 |
| EndeavorRx (DEN200026) | Akili Interactive Labs, Inc. | 2020-06-15 |
Track QFT automatically
Every clearance here is in the API, with alerts when new ones post.